What happened: Maharashtra FDA notices on “Vimal Elaichi” endorsements
Maharashtra Food and Drug Administration (FDA) issued notices to three actors connected to “Vimal Elaichi” endorsement advertisements. Maharashtra FDA alleged that the advertisements may amount to surrogate promotion of prohibited “Vimal Pan Masala.”
Advertisement elements highlighted by Maharashtra FDA
Maharashtra FDA’s concern focuses on whether advertisement elements can strengthen the consumer’s association with pan masala/tobacco and with the identity of the prohibited product. Maharashtra FDA pointed to the following advertisement components:
• Brand name used in the advertisement • Visuals and presentation style • Dialogue or spoken messaging • Market identity—how the advertisement positions the product in consumer perception
15-day response window and possible consequences
Related current affairs
- The ‘Vimal Elaichi’ promotion question
- THE GIST (for ‘Vimal Elaichi’ promotion question)
- FSSAI pulls up Swiggy Instamart for supply of alleged rotten/expired food items
- INBRIEF: SC slams FSSAI over delay in front-of-pack warning labels
- FSSAI bans ‘100% pure’ Dabur products, firm’s share falls 4%
- Bombay HC pulls up FDA for clean chit to State govt. canteens